Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors.

Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R.

Arthritis Rheum. 2010 Mar;62(3):683-93. doi: 10.1002/art.27304.

2.

Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.

Thiel MJ, Schaefer CJ, Lesch ME, Mobley JL, Dudley DT, Tecle H, Barrett SD, Schrier DJ, Flory CM.

Arthritis Rheum. 2007 Oct;56(10):3347-57.

3.

Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.

Murakami Y, Akahoshi T, Aoki N, Toyomoto M, Miyasaka N, Kohsaka H.

Arthritis Rheum. 2009 Jun;60(6):1615-23. doi: 10.1002/art.24554.

4.

Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells.

Wakamatsu K, Nanki T, Miyasaka N, Umezawa K, Kubota T.

Arthritis Res Ther. 2005;7(6):R1348-59. Epub 2005 Sep 30.

5.

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Feb;50(2):650-9.

6.

Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.

Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D.

Arthritis Rheum. 2008 Dec;58(12):3684-92. doi: 10.1002/art.24140.

7.

The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.

Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, van den Hoogen FH, van den Berg WB, Radstake TR.

Arthritis Rheum. 2005 Aug;52(8):2313-22.

8.

Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition.

Bainbridge J, Madden L, Essex D, Binks M, Malhotra R, Paleolog EM.

Arthritis Res Ther. 2007;9(6):R127.

9.

A Rac1 inhibitory peptide suppresses antibody production and paw swelling in the murine collagen-induced arthritis model of rheumatoid arthritis.

Abreu JR, Dontje W, Krausz S, de Launay D, van Hennik PB, van Stalborch AM, Ten Klooster JP, Sanders ME, Reedquist KA, Vervoordeldonk MJ, Hordijk PL, Tak PP.

Arthritis Res Ther. 2010;12(1):R2. doi: 10.1186/ar2900. Epub 2010 Jan 6.

10.

Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.

Moon DO, Kim MO, Choi YH, Park YM, Kim GY.

Int Immunopharmacol. 2010 May;10(5):605-10. doi: 10.1016/j.intimp.2010.02.011. Epub 2010 Feb 23.

PMID:
20188213
11.

Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice.

Kubera M, Simbirtsev A, Mathison R, Maes M.

Psychiatry Res. 2000 Nov 20;96(3):255-66.

PMID:
11084221
12.

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.

Arthritis Rheum. 2004 May;50(5):1457-67.

13.
14.

Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis.

Beaulieu E, Ngo D, Santos L, Yang YH, Smith M, Jorgensen C, Escriou V, Scherman D, Courties G, Apparailly F, Morand EF.

Arthritis Rheum. 2010 Sep;62(9):2651-61. doi: 10.1002/art.27566.

15.

Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis.

Kitamura T, Kabuyama Y, Kamataki A, Homma MK, Kobayashi H, Aota S, Kikuchi S, Homma Y.

Am J Physiol Cell Physiol. 2008 Jan;294(1):C189-96. Epub 2007 Oct 17.

16.

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.

Young DA, Hegen M, Ma HL, Whitters MJ, Albert LM, Lowe L, Senices M, Wu PW, Sibley B, Leathurby Y, Brown TP, Nickerson-Nutter C, Keith JC Jr, Collins M.

Arthritis Rheum. 2007 Apr;56(4):1152-63.

17.

Interleukin-10 inhibition of the progression of established collagen-induced arthritis.

Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, Feldmann M.

Arthritis Rheum. 1996 Mar;39(3):495-503.

PMID:
8607899
18.

Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling.

Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA, Gay S.

Arthritis Rheum. 2003 Mar;48(3):642-50.

19.

SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.

Lee YR, Hwang JK, Lee HS, Cheon YJ, Ryu JH, Lee SI, Kwak HB, Lee SM, Kim JS, Park JW, Jeon R, Park BH.

Br J Pharmacol. 2011 Sep;164(2b):794-806. doi: 10.1111/j.1476-5381.2011.01441.x.

20.

Amelioration of experimental arthritis by a telomerase-dependent conditionally replicating adenovirus that targets synovial fibroblasts.

Chen SY, Shiau AL, Shieh GS, Su CH, Lee CH, Lee HL, Wang CR, Wu CL.

Arthritis Rheum. 2009 Nov;60(11):3290-302. doi: 10.1002/art.24940.

Supplemental Content

Support Center